CASI PHARMACEUTICALS, INC. (CASIF) Revenue 2020–2025
CASI PHARMACEUTICALS, INC. (CASIF) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$20.7MFY2025 · since FY2020: $15.0M → $20.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $20.7M | -27.4% |
| FY2024 | $28.5M | -15.8% |
| FY2023 | $33.9M | -11.0% |
| FY2022 | $38.0M | +26.7% |
| FY2021 | $30.0M | +100.1% |
| FY2020 | $15.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice